BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15382335)

  • 1. Models of Exocrine Pancreatic Neoplasms in Transgenic Mice.
    Longnecker DS
    Comp Med; 2004 Feb; 54(1):18-21. PubMed ID: 15382335
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine Tumors of the Pancreas in Transgenic Mice.
    Longnecker DS
    Comp Med; 2004 Feb; 54(1):21-2. PubMed ID: 15382338
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
    Hruban RH; Adsay NV; Albores-Saavedra J; Anver MR; Biankin AV; Boivin GP; Furth EE; Furukawa T; Klein A; Klimstra DS; Kloppel G; Lauwers GY; Longnecker DS; Luttges J; Maitra A; Offerhaus GJ; Pérez-Gallego L; Redston M; Tuveson DA
    Cancer Res; 2006 Jan; 66(1):95-106. PubMed ID: 16397221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preinvasive duct-derived neoplasms in pancreas of keratin 5-promoter cyclooxygenase-2 transgenic mice.
    Müller-Decker K; Fürstenberger G; Annan N; Kucher D; Pohl-Arnold A; Steinbauer B; Esposito I; Chiblak S; Friess H; Schirmacher P; Berger I
    Gastroenterology; 2006 Jun; 130(7):2165-78. PubMed ID: 16762637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of islet cell tumor in pTet-on/pTRE-SV40Tag double-transgenic mice model.
    Shen Q; Sun Q; Wei X; Dong J; Zhang R; Wu P; Jin Y; Feng J; Li H; Hu Y
    J Biosci Bioeng; 2007 Jul; 104(1):14-21. PubMed ID: 17697978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice.
    Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G
    J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and utilization of transgenic animal models in studies of pancreatic cancer. Pancreas Cancer Working Group.
    Pancreas; 1987; 2(4):470-2. PubMed ID: 3650908
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular changes in pancreatic cancer.
    Buchholz M; Gress TM
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1487-97. PubMed ID: 19828010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A spontaneous acinar cell carcinoma model for monitoring progression of pancreatic lesions and response to treatment through noninvasive bioluminescence imaging.
    Zhang N; Lyons S; Lim E; Lassota P
    Clin Cancer Res; 2009 Aug; 15(15):4915-24. PubMed ID: 19622581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic technologies.
    Montag A
    Anat Rec; 1993 May; 236(1):147-50; discussion 150-1. PubMed ID: 8507000
    [No Abstract]   [Full Text] [Related]  

  • 11. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer.
    Hanahan D; Wagner EF; Palmiter RD
    Genes Dev; 2007 Sep; 21(18):2258-70. PubMed ID: 17875663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid procedure to evaluate foreign DNA transfer into mammals.
    Pinkert CA
    Biotechniques; 1990 Jul; 9(1):38-9. PubMed ID: 2203385
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased expression of Smad6 deteriorates murine acute experimental pancreatitis in two models.
    Nakamura H; Tashiro M; Asaumi H; Nomiyama Y; Kaku M; Watanabe S; Miyamoto T; Otsuki M
    Gut; 2008 Jun; 57(6):788-98. PubMed ID: 18477679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of epiplakin1 in pancreas, pancreatic cancer and regenerating pancreas.
    Yoshida T; Shiraki N; Baba H; Goto M; Fujiwara S; Kume K; Kume S
    Genes Cells; 2008 Jul; 13(7):667-78. PubMed ID: 18498355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of Ovarian Neoplasms in Genetically Modified Mice.
    Nikitin AY; Connolly DC; Hamilton TC
    Comp Med; 2004 Feb; 54(1):26-8. PubMed ID: 15382342
    [No Abstract]   [Full Text] [Related]  

  • 16. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
    Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
    Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of Mouse Models of Human Lung Cancer.
    Shmidt EN; Nitkin AY
    Comp Med; 2004 Feb; 54(1):23-6. PubMed ID: 15382341
    [No Abstract]   [Full Text] [Related]  

  • 18. Ductal pancreatic cancer in humans and mice.
    Tuveson DA; Hingorani SR
    Cold Spring Harb Symp Quant Biol; 2005; 70():65-72. PubMed ID: 16869739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of the pancreas and pancreatic cancer.
    Lewis BC
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):397-404, xi. PubMed ID: 16632101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude mice.
    Tsuji K; Yang M; Jiang P; Maitra A; Kaushal S; Yamauchi K; Katz MH; Moossa AR; Hoffman RM; Bouvet M
    JOP; 2006 Mar; 7(2):193-9. PubMed ID: 16525203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.